Detalhe da pesquisa
1.
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe.
HIV Med
; 23(6): 684-692, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882940
2.
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study.
HIV Med
; 23(6): 585-598, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34889022
3.
Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015.
Euro Surveill
; 23(21)2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29845931
4.
Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV.
Cancers (Basel)
; 15(14)2023 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509301
5.
Prevalence and Structure of HIV-1 Drug Resistance to Antiretrovirals in the Volga Federal District in 2008-2019.
Viruses
; 14(9)2022 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36146704
6.
Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations.
AIDS
; 32(18): 2807-2819, 2018 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30289816
7.
Uptake of tenofovir-based antiretroviral therapy among HIV-HBV-coinfected patients in the EuroSIDA study.
Antivir Ther
; 23(5): 405-413, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29303483
8.
Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study.
Medicine (Baltimore)
; 95(40): e5020, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27749561